This is an exciting time to join our cutting-edge organization! ModeX Therapeutics, an OPKO Health company, is developing the next generation of multi-specific antibodies as novel therapies for cancer and infectious diseases, as well as nanoparticle technologies for the development of next generation vaccines. Join our team of groundbreaking scientists today and change the world tomorrow.
ModeX Therapeutics, an OPKO Health Company, is seeking a highly skilled and motivated senior scientist /principal scientist with expertise in vector development and gene delivery to join our team. The principal responsibilities of his/her role will be to carry out early research project from developing novel vector system to evaluation of novel gene transfer technologies using in vitro assays and in vivo animal models. The individual will work in the state-of-the-art laboratory and be responsible for experimental planning and execution, data analysis and presentation. This is an exciting opportunity to be part of a cross-functional team and contribute to the development of next-generation synthetic biology therapeutics in a fast-paced, rapidly growing biotech company with a bold vision.
Major responsibilities
Qualifications
The Company
ModeX is a clinical-stage biopharmaceutical company developing next-generation antibodies and vaccines for cancer and infectious disease. ModeX's modular antibody platforms unite the power of multiple biologic components in a single molecule to create multispecific antibodies with greater versatility and potency to fight complex disease than traditional approaches. Our pipeline includes candidates against both solid and liquid tumors as well as several of the world’s most pressing viral threats. Our founding team includes globally recognized medical innovators with proven track records of delivering breakthroughs for patients. ModeX is an OPKO Health Company based in Natick, Massachusetts. For more information see modextx.com.
ModeX Therapeutics is an Equal Opportunity Employer
Software Powered by iCIMS
www.icims.com